BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35018451)

  • 21. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
    Cirulli ET; Nicoletti P; Abramson K; Andrade RJ; Bjornsson ES; Chalasani N; Fontana RJ; Hallberg P; Li YJ; Lucena MI; Long N; Molokhia M; Nelson MR; Odin JA; Pirmohamed M; Rafnar T; Serrano J; Stefánsson K; Stolz A; Daly AK; Aithal GP; Watkins PB; ;
    Gastroenterology; 2019 May; 156(6):1707-1716.e2. PubMed ID: 30664875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
    Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
    Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
    Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N
    Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease.
    Dhillon SS; Fattouh R; Elkadri A; Xu W; Murchie R; Walters T; Guo C; Mack D; Huynh HQ; Baksh S; Silverberg MS; Griffiths AM; Snapper SB; Brumell JH; Muise AM
    Gastroenterology; 2014 Sep; 147(3):680-689.e2. PubMed ID: 24931457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Vitamin D Receptor Polymorphisms With the Risk of Nonmelanoma Skin Cancer in Adults.
    Burns EM; Guroji P; Ahmad I; Nasr HM; Wang Y; Tamimi IA; Stiefel E; Abdelgawwad MS; Shaheen A; Muzaffar AF; Bush LM; Hurst CB; Griffin RL; Elmets CA; Yusuf N
    JAMA Dermatol; 2017 Oct; 153(10):983-989. PubMed ID: 28832880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
    Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
    Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan.
    Wang CC; Tang CH; Wang CY; Huang SY; Sue YM
    Br J Dermatol; 2016 Dec; 175(6):1175-1182. PubMed ID: 27273242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease.
    Wang MH; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA
    J Crohns Colitis; 2019 Aug; 13(8):1036-1043. PubMed ID: 30689765
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Scola L; Bongiorno MR; Forte GI; Aiello A; Accardi G; Scrimali C; Spina R; Lio D; Candore G
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis.
    Gil-Quiñones SR; Sepúlveda-Pachón IT; Sánchez Vanegas G; Gutierrez-Castañeda LD
    PLoS One; 2021; 16(11):e0258499. PubMed ID: 34735462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonmelanoma skin cancer and risk for subsequent malignancy.
    Chen J; Ruczinski I; Jorgensen TJ; Yenokyan G; Yao Y; Alani R; Liégeois NJ; Hoffman SC; Hoffman-Bolton J; Strickland PT; Helzlsouer KJ; Alberg AJ
    J Natl Cancer Inst; 2008 Sep; 100(17):1215-22. PubMed ID: 18728282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.
    Serrano A; Márquez A; Mackie SL; Carmona FD; Solans R; Miranda-Filloy JA; Hernández-Rodríguez J; Cid MC; Castañeda S; Morado IC; Narváez J; Blanco R; Sopeña B; García-Villanueva MJ; Monfort J; Ortego-Centeno N; Unzurrunzaga A; Marí-Alfonso B; Sánchez Martín J; de Miguel E; Magro C; Raya E; ; ; Braun N; Latus J; Molberg O; Lie BA; Moosig F; Witte T; Morgan AW; González-Gay MA; Martín J
    Ann Rheum Dis; 2013 Nov; 72(11):1882-1886. PubMed ID: 23946333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
    Ariyaratnam J; Subramanian V
    Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
    Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Xie D; Yang YX
    Adv Ther; 2021 May; 38(5):2586-2598. PubMed ID: 33844132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
    Wu S; Xie S; Yuan C; Yang Z; Liu S; Zhang Q; Sun F; Wu J; Zhan S; Zhu S; Zhang S
    Inflamm Bowel Dis; 2023 Mar; 29(3):384-395. PubMed ID: 35639937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
    Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
    Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer.
    Besson C; Moore A; Wu W; Vajdic CM; de Sanjose S; Camp NJ; Smedby KE; Shanafelt TD; Morton LM; Brewer JD; Zablotska L; Engels EA; Cerhan JR; Slager SL; Han J; Berndt SI;
    Int J Epidemiol; 2021 Aug; 50(4):1325-1334. PubMed ID: 33748835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TiO
    Schwarzfischer M; Niechcial A; Handler K; Morsy Y; Wawrzyniak M; Laimbacher AS; Atrott K; Manzini R; Baebler K; Hering L; Katkeviciutė E; Häfliger J; Lang S; Keller ME; Woodtli J; Eisenbeiss L; Kraemer T; Schraner EM; Wiesendanger M; Zeissig S; Rogler G; Moor AE; Scharl M; Spalinger MR
    Gut; 2023 Jun; 72(6):1101-1114. PubMed ID: 36191962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High plasma 25-hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individuals.
    Winsløw UC; Nordestgaard BG; Afzal S
    Br J Dermatol; 2018 Jun; 178(6):1388-1395. PubMed ID: 29143981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.